Atlas Trials

A Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis

Clinical trial NCT03022617 · COMPLETED

Trial details

NCT number
NCT03022617
Sponsor
University of Alabama at Birmingham
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriatic NailPsoriasis VulgarisPsoriasis
Start date
2017-01-01
Primary completion
2020-09-01
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.